Trial Profile
A randomized controlled trial to evaluate intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Branch retinal vein occlusion; Oedema
- Focus Therapeutic Use
- 30 Oct 2015 New trial record